Human parvovirus B19: a mechanistic overview of infection and DNA replication

被引:53
|
作者
Luo, Yong [1 ]
Qiu, Jianming [1 ]
机构
[1] Univ Kansas Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA
关键词
B19V; cell cycle; DDR; DNA damage response; DNA replication; Epo/EpoR signaling; human parvovirus B19; hypoxia; tropism; CELL-CYCLE ARREST; ERYTHROID PROGENITOR CELLS; HUMAN-BONE MARROW; DAMAGE RESPONSE; S-PHASE; MINUTE VIRUS; VIRAL-DNA; IN-VITRO; B19-ASSOCIATED MYOCARDITIS; MOLECULAR CHARACTERIZATION;
D O I
10.2217/FVL.14.103
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human parvovirus B19 (B19V) is a human pathogen that belongs to genus Erythroparvovirus of the Parvoviridae family, which is composed of a group of small DNA viruses with a linear single-stranded DNA genome. B19V mainly infects human erythroid progenitor cells and causes mild to severe hematological disorders in patients. However, recent clinical studies indicate that B19V also infects nonerythroid lineage cells, such as myocardial endothelial cells, and may be associated with other disease outcomes. Several cell culture systems, including permissive and semipermissive erythroid lineage cells, nonpermissive human embryonic kidney 293 cells and recently reported myocardial endothelial cells, have been used to study the mechanisms underlying B19V infection and B19V DNA replication. This review aims to summarize recent advances in B19V studies with a focus on the mechanisms of B19V tropism specific to different cell types and the cellular pathways involved in B19V DNA replication including cellular signaling transduction and cell cycle arrest.
引用
收藏
页码:155 / 167
页数:13
相关论文
共 50 条
  • [11] Parvovirus B19 Infection
    Mende, Marika
    Sockel, Katja
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24): : 2361 - 2361
  • [12] Diagnosis and management of human parvovirus B19 infection
    Ramirez, MM
    Mastrobattista, JM
    CLINICS IN PERINATOLOGY, 2005, 32 (03) : 697 - +
  • [13] Human parvovirus B19 infection in an immunocompromised host
    Pandey, Soumya
    CLINICAL CASE REPORTS, 2020, 8 (12): : 3609 - 3610
  • [14] RISKS ASSOCIATED WITH HUMAN PARVOVIRUS B19 INFECTION
    不详
    ARCHIVES OF DERMATOLOGY, 1989, 125 (04) : 475 - 480
  • [15] Human parvovirus B19 infection and antiphospholipid antibodies
    von Landenberg, Philipp
    Lehmann, Hartwig W.
    Modrow, Susanne
    AUTOIMMUNITY REVIEWS, 2007, 6 (05) : 278 - 285
  • [16] HUMAN PARVOVIRUS B19 INFECTION DURING PREGNANCY
    WOERNLE, CH
    ANDERSON, LJ
    TATTERSALL, P
    DAVISON, JM
    JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (01): : 17 - 20
  • [17] Renal involvement in human parvovirus B19 infection
    Toru Watanabe
    Pediatric Nephrology, 2003, 18 : 966 - 967
  • [18] Neurological manifestations of human parvovirus B19 infection
    Barah, F
    Vallely, PJ
    Cleator, GM
    Kerr, JR
    REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (03) : 185 - 199
  • [19] Hyperthyroidism associated with human parvovirus B19 infection
    Seishima, M.
    Shibuya, Y.
    Suzuki, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (07) : e439 - e440
  • [20] The cutaneous manifestations of human parvovirus B19 infection
    Magro, CM
    Dawood, MR
    Crowson, AN
    HUMAN PATHOLOGY, 2000, 31 (04) : 488 - 497